FOLLOWUS
Endorsement of CONSORT by Chinese medical journals: A survey of “instruction to authors”
Endorsement of CONSORT by Chinese medical journals: A survey of “instruction to authors”
- 中国结合医学杂志（英文版） 2014年20卷第7期 页码：510-515
- Affiliations：
1. Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine,Tianjin,China
2. First Hospital Affiliated to Tianjin University of Traditional Chinese Medicine,Tianjin,China
3. Evidence-Based Medicine Center, Tianjin University of Traditional Chinese Medicine,Tianjin,China
4. Department of Epidemiology and Biostatistics, School of Public Health, Peking University,Beijing,China
- Author bio：
- Funds：These two authors contributed equally to this work
DOI：10.1007/s11655-014-1865-8
中图分类号：纸质出版日期：2014，
网络出版日期：2014-6-28，
Scan for full text
Xiao, L., Hu, J., Zhang, L. et al. Endorsement of CONSORT by Chinese medical journals: A survey of “instruction to authors”., Chin. J. Integr. Med. 20, 510–515 (2014). https://doi.org/10.1007/s11655-014-1865-8
Lu Xiao, Jing Hu, Li Zhang, et al. Endorsement of CONSORT by Chinese medical journals: A survey of “instruction to authors”[J]. Chinese Journal of Integrative Medicine, 2014,20(7):510-515.
Xiao, L., Hu, J., Zhang, L. et al. Endorsement of CONSORT by Chinese medical journals: A survey of “instruction to authors”., Chin. J. Integr. Med. 20, 510–515 (2014). https://doi.org/10.1007/s11655-014-1865-8 DOI：
Lu Xiao, Jing Hu, Li Zhang, et al. Endorsement of CONSORT by Chinese medical journals: A survey of “instruction to authors”[J]. Chinese Journal of Integrative Medicine, 2014,20(7):510-515. DOI： 10.1007/s11655-014-1865-8.
摘要
To determine the extent to which Chinese medical (CM) journals incorporate Consolidated Standards for Reporting of Trials (CONSORT) into their “instruction to authors”. We reviewed the latest “instruction to authors” of the CM journals in China which indexed by MEDLINE in 2010 or Excerpta Medica Database (EMBASE) in 2012 and extracted all information of CONSORT
International Committee of Medical Journal Editors (ICMJE)
other reporting guidelines or clinical trial registration. By reading the instructions to authors and reviewing recent studies published in those journals
those that do not publish clinical trials were excluded. We also contacted each of journals by telephone on contributor’s status to ask them whether mentioned CONSORT in their instructions and incorporated it into their editorial and peer-review process. Full-text papers of randomized controlled trials (RCTs
from January 2011 to March 2012) published in the journals which mentioned “CONSORT” in their instructions for authors were downloaded. Seven CM journals were included. Three of these journals mentioned CONSORT in its instructions. By telephone survey
all journals gave responses and all respondents knew CONSORT statement. Three of 7 journals required authors to comply with the CONSORT statement and provide the CONSORT checklist and a flow chart of the trial. The rest 4 journals recommended authors of RCTs to refer to the CONSORT statement. From January 2011 to March 2012
a total of 50 RCTs were obtained from the 3 journals endorsing the CONSORT statement; 17 (17/50
34%) contained a flow diagram in their manuscript
and none of those RCTs had mentioned the trial registration information. The endorsement of CONSORT by CM journals’ “instruction to authors” was not satisfactory. The spread of CONSORT endorsement should be wider in instructing the performance of CM clinical trials in the future. Chinese journals should introduce CONSORT to their authors and require authors to comply with CONSORT when they submit their research.
Abstract
To determine the extent to which Chinese medical (CM) journals incorporate Consolidated Standards for Reporting of Trials (CONSORT) into their “instruction to authors”. We reviewed the latest “instruction to authors” of the CM journals in China which indexed by MEDLINE in 2010 or Excerpta Medica Database (EMBASE) in 2012 and extracted all information of CONSORT
International Committee of Medical Journal Editors (ICMJE)
other reporting guidelines or clinical trial registration. By reading the instructions to authors and reviewing recent studies published in those journals
those that do not publish clinical trials were excluded. We also contacted each of journals by telephone on contributor’s status to ask them whether mentioned CONSORT in their instructions and incorporated it into their editorial and peer-review process. Full-text papers of randomized controlled trials (RCTs
from January 2011 to March 2012) published in the journals which mentioned “CONSORT” in their instructions for authors were downloaded. Seven CM journals were included. Three of these journals mentioned CONSORT in its instructions. By telephone survey
all journals gave responses and all respondents knew CONSORT statement. Three of 7 journals required authors to comply with the CONSORT statement and provide the CONSORT checklist and a flow chart of the trial. The rest 4 journals recommended authors of RCTs to refer to the CONSORT statement. From January 2011 to March 2012
a total of 50 RCTs were obtained from the 3 journals endorsing the CONSORT statement; 17 (17/50
34%) contained a flow diagram in their manuscript
and none of those RCTs had mentioned the trial registration information. The endorsement of CONSORT by CM journals’ “instruction to authors” was not satisfactory. The spread of CONSORT endorsement should be wider in instructing the performance of CM clinical trials in the future. Chinese journals should introduce CONSORT to their authors and require authors to comply with CONSORT when they submit their research.
关键词
Consolidated Standards for Reporting of Trialsrandomized controlled trialChinese medical journalinstruction to authorsreporting quality
Keywords
Consolidated Standards for Reporting of Trialsrandomized controlled trialChinese medical journalinstruction to authorsreporting quality
references
Xu L, Li J, Zhang MM, Ai CL, Wang L. Chinese authors do need CONSORT: Reporting quality assessment for five leading Chinese medical journals. Contemp Clin Trials 2008;29:727–731.
Folkes A, Urquhart R, Grunfeld E. Are leading medical journals following their own policies on CONSORT reporting? Contemp Clin Trials 2008;29:843–846.
Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996;276:637–639.
Davidoff F. News from the International Committee of Medical Journal Editors. Ann Intern Med 2000;133:229–231.
Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. PLoS Med 2010;7:e1000251. doi:10.1371/journal.pmed.1000251
Wu TX, Li YP, Bian ZX, Li TQ, Li J, Dagenais S, et al. Consolidated standards for reporting trials of traditional Chinese medicine (CONSORT for TCM). Chin J Evid-based Med (Chin) 2007;7:625–630.
Plint AC, Moher D, Morrison A, Schulz K, Altman DG, Hill C, et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J 2006;185:263–267.
Altman DG. Endorsement of the CONSORT statement by high impact medical journals: survey of instructions for authors. BMJ 2005;330:1056–1057.
Hopewell S, Altman DG, Moher D, Schulz KF. Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal’ Instructions to Authors’. Trials 2008;9:20.
Li XQ, Tao KM, Zhou QH, Moher D, Chen HY, Wang FZ, et al. Endorsement of the CONSORT statement by high-impact medical journals in China: a survey of Iinstructions for authors and published papers. PLoS ONE 2012;7:e30683. doi:10.1371/journal.pone.0030683
Egger M, Jüni P, Bartlett C. Value of flow diagrams in reports of randomized controlled trials. JAMA 2001;285:1996–1999.
Wright JR, Bouma S, Dayes I, Sussman J, Simunovic MR, Levine MN, et al. The importance of reporting patient recruitment details in phase III trials. J Clin Oncol 2006;24:843–845.
Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA 2007;297:1233–1240.
Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.
De Angelisa C, Drazenb JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet 2004;364:911–912.
Why is trial registration important? 2012, http://www.who.int/ictrp/trial_reg/en/index.htmlint/ictrp/trial_reg/en/index.html
Zhang C, Zha QL, He YT, Jiang M, Lv C, Lv AP. The extraarticular symptoms influence ACR response in the treatment of rheumatoid arthritis with biomedicine: a singleblind, randomized, controlled, multicenter trial in 194 patients. J Tradit Chin Med 2011;31:50–55.
Shi ZF, Zhou QQ, Xiang L, Ma SD, Yan CJ, Luo H. Three preparations of compound Chinese herbal medicines for de-adaptation to high altitude: a randomized, placebocontrolled trial. J Chin Integr Med (Chin) 2011;9:395–401.
Wang TF, Xue XL, Zhang YJ, Han P, Li Z, Wang WP, et al. Effects of Xiaopi Yishen herbal extract granules in treatment of fatigue-predominant subhealth due to Liverqi stagnation and Spleen-qi deficiency: a prospective, randomized, placebo-controlled and double-blind clinical trial. J Chin Integr Med (Chin) 2011;9:515–524.
Susuana Kuek, Wang WJ, Gui SQ. Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial. J Chin Integr Med (Chin) 2011;9:395–401.
Yan GY, Xu ZY, Deng HB, Wan ZY, Zhang L, Zhu JY. Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao Decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial. J Chin Integr Med (Chin) 2011;9:525–530.
Zheng ZX, Wang J, Hou JS, Ma L, Jiang CB. A traditional Chinese medicine therapy warming meridians to nourish blood in treating chronic pain due to soft tissue injury of the neck and shoulder: a randomized controlled trial. J Chin Integr Med (Chin) 2011;9:153–157.
Zheng ZX, Wang J, Hou JS, Ma L, Jiang CB. A traditional Chinese medicine therapy warming meridians to nourish blood in treating chronic pain due to soft tissue injury of the neck and shoulder: a randomized controlled trial. J Chin Integr Med (Chin) 2011;9:153–157.
Wei XL, Feng R, Zhao ZQ, Jing ZP. Efficacy of Chinese herbal medicine Mailuo Shutong Granule and Hirudoid cream for chronic venous disorder-induced pigmentation in lower extremities: a prospective, randomized controlled trial. J Chin Integr Med (Chin) 2011;9:866–870.
Shu S, Li TM, Fang FF, He HL, Zhou QH, Gu W, et al. Relieving pre-exam anxiety syndrome with wrist-ankle acupuncture: a randomized controlled trial. J Chin Integr Med (Chin) 2011;9:605–610.
Chen I, Bi XY, Zhu LX, Qiu YQ, Ding S, Deng BQ. Flavonoids of puerarin versus tanshinone j1 A for ischemic stroke: a randomized controlled trial. J Chin Inter Med (Chin) 2011;9:1215–1220.
Guo LK. Zhang CX, Guo XF. Acupuncture combined with Chinese herbal medicine plantain and Senna Granule in treatment of functional constipation: a randomized, controlled trial. J Chin Integr Med (Chin) 2011;9:1206–1214.
Li M, Yang MH, Liu Y. Effects of Chinese herbal medicine Bushen Huoxue Granule on quality of life of patients with Parkinson disease: a randomized, double blinded and placebo controlled trial. J Chin Integr Med (Chin) 2012;10:310–317.
Zhu YF, Luo HM, Deng ZL, Fu DY, Yao W, Dai J. Effects of the Chinese patent medicine, Honghua Injection, on platelet glycoprotein IIb/IIIa receptors in patients with acute coronary syndrome: a randomized controlled trial. J Chin Integr Med (Chin) 2012;10:318–323.
Li BS, Li ZH, Tang XD, Zhang LY, Zhao YP, Bian LQ, et al. A randomized, controlled, double-blinded and doubledummy trial of the effect of Tongjiang Granule (通降颗粒) on the nonerosive reflux disease of and Gan (肝)-Wei (胃) incoordination syndrome. Chin J Integr Med 2011;17:339–345.
Cao B, Li ST, Li Z, Deng WL. Yiqi Zhuyu Decoction (益 气逐瘀汤) combined with FOLFOX-4 as first-line therapy in metastatic colorectal cancer. Chin J Integr Med 2011;17:593–599.
Lu CJ, Xiang Y, Xie XL, Yi ML, He ZH. A randomized controlled single-blind clinical trial on 84 outpatients with psoriasis vulgaris by auricular therapy combined with optimized Yinxieling Formula (银屑灵优化方). Chin J Integr Med 2012;8:186–191.
0
浏览量
816
Downloads
6
CSCD
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 邮编：100091
- 联系电话：010-62886827, 62877592 传真：010-62874291
- 技术支持由北京北大方正电子有限公司提供 京ICP备05067934号-1
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
